Zi‐Niu Ding
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Cancer Immunotherapy and Biomarkers
- Inflammatory Biomarkers in Disease Prognosis
Papers in
- Epidemiology 11
- Liver Disease Diagnosis and Treatment 6
- Hepatitis B Virus Studies 4
- Oncology 10
- Cancer Immunotherapy and Biomarkers 7
- Co-authors
- Zhao‐Ru Dong (41 shared papers)Tao Li (41 shared papers)Lun‐Jie Yan (39 shared papers)Dongxu Wang (28 shared papers)Zhiqiang Chen (19 shared papers)Yu‐Chuan Yan (30 shared papers)Jian‐Guo Hong (18 shared papers)Hui Liu (19 shared papers)
In The Last Decade
Zi‐Niu Ding
41 papers receiving 424 citations
Peers
Comparison fields: 5 of 51
- Hepatology 95
- Oncology 149
- Cancer Research 51
- Epidemiology 81
- Immunology 49
Countries citing papers authored by Zi‐Niu Ding
This map shows the geographic impact of Zi‐Niu Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zi‐Niu Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zi‐Niu Ding more than expected).
Fields of papers citing papers by Zi‐Niu Ding
This network shows the impact of papers produced by Zi‐Niu Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zi‐Niu Ding. The network helps show where Zi‐Niu Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Zi‐Niu Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 80 | |
| 2 | 2021 | 28 | |
| 3 | 2022 | 28 | |
| 4 | 2022 | 25 | |
| 5 | 2022 | 17 | |
| 6 | 2023 | 16 | |
| 7 | 2023 | 15 | |
| 8 | 2023 | 13 | |
| 9 | 2022 | 13 | |
| 10 | 2024 | 11 | |
| 11 | 2021 | 11 | |
| 12 | 2022 | 10 | |
| 13 | 2021 | 10 | |
| 14 | 2021 | 10 | |
| 15 | 2021 | 10 | |
| 16 | 2023 | 9 | |
| 17 | 2023 | 9 | |
| 18 | 2022 | 9 | |
| 19 | 2023 | 9 | |
| 20 | 2014 | 9 |
About Zi‐Niu Ding
Zi‐Niu Ding is a scholar working on Epidemiology, Oncology, Hepatology, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 45 papers that have together received 435 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), Liver Disease Diagnosis and Treatment (6 papers), Ferroptosis and cancer prognosis (4 papers), Hepatitis B Virus Studies (4 papers), RNA modifications and cancer (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Hepatology (95 citations), Oncology (149 citations), Cancer Research (51 citations), Epidemiology (81 citations) and Immunology (49 citations). Zi‐Niu Ding has collaborated with scholars based in China and Sweden. Frequent co-authors include Zhao‐Ru Dong, Tao Li, Lun‐Jie Yan, Dongxu Wang, Zhiqiang Chen, Yu‐Chuan Yan, Jian‐Guo Hong, Hui Liu, Bao‐Wen Tian and Jun-Shuai Xue. Their work appears in journals such as Frontiers in Immunology, Cell Death and Disease, Journal of Cancer Research and Clinical Oncology, Journal of Gastroenterology and Hepatology and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.